ADI-PEG 20 Uses, Dosage, Side Effects and more
ADI-PEG 20 is an anticancer agent.
| Attribute | Details |
|---|---|
| Trade Name | ADI-PEG 20 |
| Generic | Pegargiminase |
| Pegargiminase Other Names | ADI-PEG 20, Arginine deiminase pegylated, Pegargiminase, Pegylated arginine deiminase |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in melanoma and hepatocellular carcinoma.
